Compare Hemodynamic Profile Of Intrathecal Hyperbaric Bupivacaine 0.5 percent Versus Hyperbaric Levobupivacaine 0.5 percent in Elderly Population Undergoing Infraumbilical Surgeries

Randomized Double Blind Study To Compare Hemodynamic Profile Of Intrathecal Hyperbaric Bupivacaine 0.5 percent Versus Hyperbaric Levobupivacaine 0.5 percent in Elderly Population Undergoing Infraumbilical Surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/093955

Enrollment

Registered

2025-09-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj Bupivacaine 0.5 percent heavy 3.2 ml given intrathecally once prior to surgery: Inj Bupivacaine 0.5 percent Heavy refers to a 0.5 percent solution of bupivacaine that is heavy or hy

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with ASA grade II,III. 2.Patient undergoing elective infra umbilical surgeries in supine position under Spinal anesthesia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To compare hemodynamic parameters(SBP/DBP/MAP) of intrathecal hyperbaric Bupivacaine 0.5 percent with hyperbaric Levobupivacaine 0.5 percent post spinal anaesthesia in ASA II and III elderly population undergoing infraumbilical surgeries.Timepoint: From 1 minute of administration of spinal anaesthesia till one hour	—

Secondary

Measure	Time frame
To campare requirement of vasopressor between two groupsTimepoint: From 1 minutes of spinal anaesthesia till end of surgery;To compare Duration of analgesia between the two groupsTimepoint: From 1 minute of spinal anaesthesia till 1 day	—

Countries

India

Contacts

Public ContactShubhada S Aphale

Bharati Vidyapeeth (Deemed to be university)Medical college,Pune.

subhada.aphale@yahoo.com9850968630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026